IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v15y2024i1d10.1038_s41467-024-48414-x.html
   My bibliography  Save this article

Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters

Author

Listed:
  • Luca M. Zaeck

    (Erasmus University Medical Center)

  • Ngoc H. Tan

    (Erasmus University Medical Center)

  • Wim J. R. Rietdijk

    (Erasmus University Medical Center)

  • Daryl Geers

    (Erasmus University Medical Center)

  • Roos S. G. Sablerolles

    (Erasmus University Medical Center)

  • Susanne Bogers

    (Erasmus University Medical Center)

  • Laura L. A. Dijk

    (Erasmus University Medical Center)

  • Lennert Gommers

    (Erasmus University Medical Center)

  • Leanne P. M. Leeuwen

    (Erasmus University Medical Center)

  • Sharona Rugebregt

    (Erasmus University Medical Center)

  • Abraham Goorhuis

    (Amsterdam University Medical Centers
    Amsterdam Public Health, University of Amsterdam)

  • Douwe F. Postma

    (University Medical Center Groningen)

  • Leo G. Visser

    (Leiden University Medical Center)

  • Virgil A. S. H. Dalm

    (Division of Allergy and Clinical Immunology, Erasmus University Medical Center
    Erasmus University Medical Center)

  • Melvin Lafeber

    (Erasmus University Medical Center)

  • Neeltje A. Kootstra

    (Amsterdam Institute for Immunology and Infectious Diseases, University of Amsterdam)

  • Anke L. W. Huckriede

    (University Medical Center Groningen, University of Groningen)

  • Bart L. Haagmans

    (Erasmus University Medical Center)

  • Debbie Baarle

    (University Medical Center Groningen, University of Groningen
    National Institute for Public Health and the Environment)

  • Marion P. G. Koopmans

    (Erasmus University Medical Center)

  • P. Hugo M. Kuy

    (Erasmus University Medical Center)

  • Corine H. GeurtsvanKessel

    (Erasmus University Medical Center)

  • Rory D. Vries

    (Erasmus University Medical Center)

Abstract

Waning antibody responses after COVID-19 vaccination combined with the emergence of the SARS-CoV-2 Omicron lineage led to reduced vaccine effectiveness. As a countermeasure, bivalent mRNA-based booster vaccines encoding the ancestral spike protein in combination with that of Omicron BA.1 or BA.5 were introduced. Since then, different BA.2-descendent lineages have become dominant, such as XBB.1.5, JN.1, or EG.5.1. Here, we report post-hoc analyses of data from the SWITCH-ON study, assessing how different COVID-19 priming regimens affect the immunogenicity of bivalent booster vaccinations and breakthrough infections (NCT05471440). BA.1 and BA.5 bivalent vaccines boosted neutralizing antibodies and T-cells up to 3 months after boost; however, cross-neutralization of XBB.1.5 was poor. Interestingly, different combinations of prime-boost regimens induced divergent responses: participants primed with Ad26.COV2.S developed lower binding antibody levels after bivalent boost while neutralization and T-cell responses were similar to mRNA-based primed participants. In contrast, the breadth of neutralization was higher in mRNA-primed and bivalent BA.5 boosted participants. Combined, our data further support the current use of monovalent vaccines based on circulating strains when vaccinating risk groups, as recently recommended by the WHO. We emphasize the importance of the continuous assessment of immune responses targeting circulating variants to guide future COVID-19 vaccination policies.

Suggested Citation

  • Luca M. Zaeck & Ngoc H. Tan & Wim J. R. Rietdijk & Daryl Geers & Roos S. G. Sablerolles & Susanne Bogers & Laura L. A. Dijk & Lennert Gommers & Leanne P. M. Leeuwen & Sharona Rugebregt & Abraham Goorh, 2024. "Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters," Nature Communications, Nature, vol. 15(1), pages 1-12, December.
  • Handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48414-x
    DOI: 10.1038/s41467-024-48414-x
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-024-48414-x
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-024-48414-x?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Deborah Cromer & Megan Steain & Arnold Reynaldi & Timothy E. Schlub & Shanchita R. Khan & Sarah C. Sasson & Stephen J. Kent & David S. Khoury & Miles P. Davenport, 2023. "Predicting vaccine effectiveness against severe COVID-19 over time and against variants: a meta-analysis," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    2. Ariën Schiepers & Marije F. L. Wout & Allison J. Greaney & Trinity Zang & Hiromi Muramatsu & Paulo J. C. Lin & Ying K. Tam & Luka Mesin & Tyler N. Starr & Paul D. Bieniasz & Norbert Pardi & Jesse D. B, 2023. "Molecular fate-mapping of serum antibody responses to repeat immunization," Nature, Nature, vol. 615(7952), pages 482-489, March.
    3. Wafaa B. Alsoussi & Sameer Kumar Malladi & Julian Q. Zhou & Zhuoming Liu & Baoling Ying & Wooseob Kim & Aaron J. Schmitz & Tingting Lei & Stephen C. Horvath & Alexandria J. Sturtz & Katherine M. McInt, 2023. "SARS-CoV-2 Omicron boosting induces de novo B cell response in humans," Nature, Nature, vol. 617(7961), pages 592-598, May.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Marta Ferreira-Gomes & Yidan Chen & Pawel Durek & Hector Rincon-Arevalo & Frederik Heinrich & Laura Bauer & Franziska Szelinski & Gabriela Maria Guerra & Ana-Luisa Stefanski & Antonia Niedobitek & Ann, 2024. "Recruitment of plasma cells from IL-21-dependent and IL-21-independent immune reactions to the bone marrow," Nature Communications, Nature, vol. 15(1), pages 1-16, December.
    2. Ivan V. Kuzmin & Ruben Soto Acosta & Layne Pruitt & Perry T. Wasdin & Kritika Kedarinath & Keziah R. Hernandez & Kristyn A. Gonzales & Kharighan Hill & Nicole G. Weidner & Chad Mire & Taylor B. Engdah, 2024. "Comparison of uridine and N1-methylpseudouridine mRNA platforms in development of an Andes virus vaccine," Nature Communications, Nature, vol. 15(1), pages 1-18, December.
    3. Chengzi I. Kaku & Tyler N. Starr & Panpan Zhou & Haley L. Dugan & Paul Khalifé & Ge Song & Elizabeth R. Champney & Daniel W. Mielcarz & James C. Geoghegan & Dennis R. Burton & Raiees Andrabi & Jesse D, 2023. "Evolution of antibody immunity following Omicron BA.1 breakthrough infection," Nature Communications, Nature, vol. 14(1), pages 1-13, December.
    4. Eva Stadler & Martin T. Burgess & Timothy E. Schlub & Shanchita R. Khan & Khai Li Chai & Zoe K. McQuilten & Erica M. Wood & Mark N. Polizzotto & Stephen J. Kent & Deborah Cromer & Miles P. Davenport &, 2023. "Monoclonal antibody levels and protection from COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    5. Junqing Xie & Beatriz Mothe & Marta Alcalde Herraiz & Chunxiao Li & Yu Xu & Annika M. Jödicke & Yaqing Gao & Yunhe Wang & Shuo Feng & Jia Wei & Zhuoyao Chen & Shenda Hong & Yeda Wu & Binbin Su & Xiaoy, 2024. "Relationship between HLA genetic variations, COVID-19 vaccine antibody response, and risk of breakthrough outcomes," Nature Communications, Nature, vol. 15(1), pages 1-11, December.
    6. Spyros Chalkias & Charles Harper & Keith Vrbicky & Stephen R. Walsh & Brandon Essink & Adam Brosz & Nichole McGhee & Joanne E. Tomassini & Xing Chen & Ying Chang & Andrea Sutherland & David C. Montefi, 2023. "Three-month antibody persistence of a bivalent Omicron-containing booster vaccine against COVID-19," Nature Communications, Nature, vol. 14(1), pages 1-7, December.
    7. Alexander C. Dowell & Tara Lancaster & Rachel Bruton & Georgina Ireland & Christopher Bentley & Panagiota Sylla & Jianmin Zuo & Sam Scott & Azar Jadir & Jusnara Begum & Thomas Roberts & Christine Step, 2023. "Immunological imprinting of humoral immunity to SARS-CoV-2 in children," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    8. Khadija Khan & Gila Lustig & Cornelius Römer & Kajal Reedoy & Zesuliwe Jule & Farina Karim & Yashica Ganga & Mallory Bernstein & Zainab Baig & Laurelle Jackson & Boitshoko Mahlangu & Anele Mnguni & Ay, 2023. "Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant," Nature Communications, Nature, vol. 14(1), pages 1-9, December.
    9. Bo Zhang & Youyi Fong & Jonathan Fintzi & Eric Chu & Holly E. Janes & Avi Kenny & Marco Carone & David Benkeser & Lars W. P. Laan & Weiping Deng & Honghong Zhou & Xiaowei Wang & Yiwen Lu & Chenchen Yu, 2024. "Omicron COVID-19 immune correlates analysis of a third dose of mRNA-1273 in the COVE trial," Nature Communications, Nature, vol. 15(1), pages 1-13, December.
    10. Craig A. Magaret & Li Li & Allan C. deCamp & Morgane Rolland & Michal Juraska & Brian D. Williamson & James Ludwig & Cindy Molitor & David Benkeser & Alex Luedtke & Brian Simpkins & Fei Heng & Yanqing, 2024. "Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features," Nature Communications, Nature, vol. 15(1), pages 1-22, December.
    11. Eike-Christian Wamhoff & Larance Ronsard & Jared Feldman & Grant A. Knappe & Blake M. Hauser & Anna Romanov & James Brett Case & Shilpa Sanapala & Evan C. Lam & Kerri J. St. Denis & Julie Boucau & Amy, 2024. "Enhancing antibody responses by multivalent antigen display on thymus-independent DNA origami scaffolds," Nature Communications, Nature, vol. 15(1), pages 1-13, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-48414-x. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.